1. Home
  2. PRCT vs MMS Comparison

PRCT vs MMS Comparison

Compare PRCT & MMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRCT
  • MMS
  • Stock Information
  • Founded
  • PRCT 2009
  • MMS 1975
  • Country
  • PRCT United States
  • MMS United States
  • Employees
  • PRCT N/A
  • MMS N/A
  • Industry
  • PRCT Medical Specialities
  • MMS Business Services
  • Sector
  • PRCT Health Care
  • MMS Consumer Discretionary
  • Exchange
  • PRCT Nasdaq
  • MMS Nasdaq
  • Market Cap
  • PRCT 4.7B
  • MMS 4.4B
  • IPO Year
  • PRCT 2021
  • MMS 1997
  • Fundamental
  • Price
  • PRCT $69.75
  • MMS $79.65
  • Analyst Decision
  • PRCT Strong Buy
  • MMS Buy
  • Analyst Count
  • PRCT 7
  • MMS 1
  • Target Price
  • PRCT $97.86
  • MMS $90.00
  • AVG Volume (30 Days)
  • PRCT 656.5K
  • MMS 679.0K
  • Earning Date
  • PRCT 02-25-2025
  • MMS 02-06-2025
  • Dividend Yield
  • PRCT N/A
  • MMS 1.50%
  • EPS Growth
  • PRCT N/A
  • MMS 89.73
  • EPS
  • PRCT N/A
  • MMS 4.99
  • Revenue
  • PRCT $199,843,000.00
  • MMS $5,306,197,000.00
  • Revenue This Year
  • PRCT $67.07
  • MMS $0.17
  • Revenue Next Year
  • PRCT $40.64
  • MMS $2.82
  • P/E Ratio
  • PRCT N/A
  • MMS $15.99
  • Revenue Growth
  • PRCT 71.71
  • MMS 8.19
  • 52 Week Low
  • PRCT $44.52
  • MMS $69.72
  • 52 Week High
  • PRCT $103.81
  • MMS $93.97
  • Technical
  • Relative Strength Index (RSI)
  • PRCT 25.89
  • MMS 66.35
  • Support Level
  • PRCT $79.56
  • MMS $75.89
  • Resistance Level
  • PRCT $89.49
  • MMS $78.11
  • Average True Range (ATR)
  • PRCT 4.14
  • MMS 1.62
  • MACD
  • PRCT -1.11
  • MMS 0.59
  • Stochastic Oscillator
  • PRCT 6.09
  • MMS 94.00

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.

About MMS Maximus Inc.

Maximus Inc designs, develops, and delivers programs, enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments; U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.

Share on Social Networks: